Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity
Authors:
Open Access
- 29 July 2013
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (33) , 13564-13569
Abstract
Vaccines are among the most effective approaches to prevent and control many infectious diseases. Because of safety and reproducibility concerns, whole-cell vaccines (WCVs), made from live or killed microorganisms and including hundreds of antigenic components, have been mostly replaced by acellular or subunit vaccines composed of well-defined, purified antigen components. The efficacy of acellular vaccines is inferior to that of WCVs, however, for two major reasons: limited antigen diversity and reduced immunogenicity, especially in a lack of activation of antigen-specific T-cell immunity, which plays an important role in protection against mucosal and intracellular pathogens. Here we present the multiple antigen-presenting system (MAPS), which enables the creation of a macromolecular complex that mimics the properties of WCVs by integrating various antigen components, including polysaccharides and proteins, in the same construct and that induces multipronged immune responses, including antibody, Th1, and Th17 responses. Using antigens from various pathogens (Streptococcus pneumoniae,Salmonella typhi, andMycobacterium tuberculosis), we demonstrate the versatility of the MAPS system and its feasibility for the design of unique defined-structure subunit vaccines to confer comprehensive protection via multiple immune mechanisms. Moreover, MAPS can serve as a tool for structure-activity analysis of cellular immunogens.Keywords
This publication has 35 references indexed in Scilit:
- Serotype replacement in disease after pneumococcal vaccinationThe Lancet, 2011
- A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine designNature Medicine, 2011
- Next generation pneumococcal vaccinesCurrent Opinion in Immunology, 2011
- The role of Th17 cytokines in primary mucosal immunityCytokine & Growth Factor Reviews, 2010
- GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsisVaccine, 2010
- IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in miceJournal of Clinical Investigation, 2010
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvantCellular and Molecular Life Sciences, 2008
- Th17 cells and mucosal host defenseSeminars in Immunology, 2007
- Rhizavidin from Rhizobium etli: the first natural dimer in the avidin protein familyBiochemical Journal, 2007
- Patterns of antigenic diversity and the mechanisms that maintain themJournal of The Royal Society Interface, 2007